99-1795. Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units From Prior Collections From Donors ...  

  • [Federal Register Volume 64, Number 17 (Wednesday, January 27, 1999)]
    [Notices]
    [Page 4112]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-1795]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98D-0143]
    
    
    Agency Information Collection Activities; Announcement of OMB 
    Approval; Guidance for Industry: Current Good Manufacturing Practice 
    for Blood and Blood Components: (1) Quarantine and Disposition of Units 
    From Prior Collections From Donors with Repeatedly Reactive Screening 
    Test for Antibody to Hepatitis C Virus (Anti-HCV); (2) Supplemental 
    Testing, and the Notification of Consignees and Blood Recipients of 
    Donor Test Results for Anti-HCV
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
    collection of information entitled ``Guidance for Industry: Current 
    Good Manufacturing Practice for Blood and Blood Components: (1) 
    Quarantine and Disposition of Units From Prior Collections From Donors 
    with Repeatedly Reactive Screening Test for Antibody to Hepatitis C 
    Virus (Anti-HCV); (2) Supplemental Testing, and the Notification of 
    Consignees and Blood Recipients of Donor Test Results for Anti-HCV'' 
    has been approved by the Office of Management and Budget (OMB) under 
    the Paperwork Reduction Act of 1995.
    
    FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of October 21, 1998 
    (63 FR 56192), the agency announced that the proposed information 
    collection had been submitted to OMB for review and clearance under 44 
    U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
    required to respond to, a collection of information unless it displays 
    a currently valid OMB control number. OMB has now approved the 
    information collection and has assigned OMB control number 0910-0388. 
    The approval expires on April 30, 1999.
    
        Dated: January 20, 1999.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 99-1795 Filed 1-26-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
01/27/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-1795
Pages:
4112-4112 (1 pages)
Docket Numbers:
Docket No. 98D-0143
PDF File:
99-1795.pdf